Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
diphtheria, tetanus, and poliomyelitis vaccine
- Development stage
- Approved
- Lead developer
- GSK
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The diphtheria, tetanus, and poliomyelitis vaccine (Td/IPV) is a trivalent biological product used for active immunization against three infectious diseases: diphtheria, tetanus, and poliomyelitis. It contains inactivated diphtheria and tetanus toxoids along with inactivated poliovirus (IPV) types 1, 2, and 3. The vaccine is typically administered as a booster dose in adolescents and adults to maintain immunity acquired during childhood. It works by inducing the immune system to produce specific antitoxins and neutralizing antibodies. Common brand names include REVAXIS, while versions containing additional components like pertussis (Tdap-IPV) include Adacel-Polio and Boostrix-Polio.
- Brand names
- REVAXISAdacel-PolioBoostrix-Polio
- Other names
- Td/IPVDT-IPVdiphtheria, tetanus, and inactivated poliovirus vaccine
02
Targets
Diphtheria toxin
Beyond the preview
Go deeper on diphtheria, tetanus, and poliomyelitis vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on diphtheria, tetanus, and poliomyelitis vaccine.